Criticism of pricing policy in Europe: meager income cloud Novartis’ shareholder wellness

Criticism of pricing policy in Europe Meager revenues cloud Novartis’ shareholder wellness 2/1/2023, 6:17 p.m Novartis flatters its shareholders with a higher dividend and additional billions for a possible share buyback. But on the stock exchange, this initially does not trigger any storms of jubilation. The reason for this is the missed expectations in the…

Read More

Bayer: A shareholder wants the quick replacement of the CEO, according to the press

FRANKFURT (Reuters) – Bayer shareholder Deka has requested a replacement for chief executive Werner Baumann ahead of his scheduled departure, adding to mounting pressure on the German drugmaker. “Bayer needs a new strategic positioning, which cannot be credibly achieved under the leadership of Werner Baumann,” Deka head of corporate governance Ingo Speich told the Frankfurter…

Read More

Bayer: A shareholder criticizes the lack of initiative of the president

FRANKFURT (Reuters) – Union Investment, one of Bayer’s shareholders, criticized on Sunday the group’s chairman’s lack of initiative, particularly on the planned split of the consumer healthcare division, German business weekly WirtschaftsWoche reported. Bayer is under pressure from activist investor Bluebell Capital Partners, which wants the German pharmaceutical and agrochemical group to be dismantled, including…

Read More

Metabolic Explorer: injection of 73 million euros by its main shareholder – 12/28/2022 at 08:37

(AOF) – The biochemical company Metabolic Explorer, in difficulty with the surge in energy and raw materials, announced yesterday the forthcoming injection of 73 million euros by its main shareholder, the SPI fund of the bank public Bpifrance, and private banks. AOF – LEARN MORE Learn more about the chemical sector Nothing is going well…

Read More